Clinical Trial Update: A Study of Fluvestrant Combined With Oral Vinorelbine in Hormone Receptor-positive Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring fluvestrant with oral vinorelbine in hormone receptor-positive advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone Receptor-positive Advanced Breast Cancer

Drugs mentioned

• Fluvestrant (fluvestrant)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Hormone Receptor Positive Advanced Breast Cancer | Phase 2 | Status: UNKNOWN